Ultra high performance liquid chromatography tandem mass spectrometric detection in clinical analysis of simvastatin and atorvastatin

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

Volumn 877, Issue 22, 2009, Pages 2093-2103

  Nováková, Lucie ^a   Vlčková, Hana ^a   Šatínský, Dalibor ^a   Sadílek, Petr ^a   Solichová, Dagmar ^b   Bláha, Milan ^b   Bláha, Vladimír ^b   Solich, Petr ^a  

^a Charles University in Prague Faculty of Pharmacy   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Atorvastatin; Bio analytical method; Hemodialysis; Simvastatin; Tandem mass spectrometry; UPLC

Indexed keywords

ATORVASTATIN; BIO-ANALYTICAL METHOD; HEMODIALYSIS; SIMVASTATIN; TANDEM MASS SPECTROMETRY; UPLC;

ACETONITRILE; AMMONIUM COMPOUNDS; CHOLESTEROL; CHROMATOGRAPHIC ANALYSIS; DEUTERIUM; DEUTERIUM COMPOUNDS; DIALYSIS; DRUG PRODUCTS; HEMODIALYZERS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIGH PRESSURE LIQUID CHROMATOGRAPHY; IONIZATION OF LIQUIDS; MASS SPECTROMETRY; SEMICONDUCTOR SWITCHES; SPECTRUM ANALYSIS;

MASS SPECTROMETERS;

2 HYDROXYATORVASTATIN; 4 HYDROXYATORVASTATIN; ACETONITRILE; AMMONIUM ACETATE; ATORVASTATIN; ATORVASTATIN LACTONE; DEUTERIUM; DRUG METABOLITE; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; SIMVASTATIN; SIMVASTATIN ACID; UNCLASSIFIED DRUG; VERY LOW DENSITY LIPOPROTEIN;

ACCURACY; ADULT; AGED; ARTICLE; CHEMICAL REACTION; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG BLOOD LEVEL; DRUG HALF LIFE; ELECTROSPRAY MASS SPECTROMETRY; ELUTION; EVENING DOSAGE; FEMALE; FOOD INTAKE; HEMODIALYSIS PATIENT; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYPERCHOLESTEROLEMIA; KIDNEY FAILURE; LIPID BLOOD LEVEL; MALE; PH; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; TANDEM MASS SPECTROMETRY; VALIDATION PROCESS;

AGED; AGED, 80 AND OVER; ANTICHOLESTEREMIC AGENTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HEPTANOIC ACIDS; HUMANS; HYPERCHOLESTEROLEMIA; MALE; MIDDLE AGED; PYRROLES; SENSITIVITY AND SPECIFICITY; SIMVASTATIN; TANDEM MASS SPECTROMETRY;

EID: 67649173103     PISSN: 15700232     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jchromb.2009.05.052     Document Type: Article

References (34)

1. Shitara Y., and Sugiyama Y. Pharmacol. Ther. 112 (2006) 71
2. World Health Organization, World Health Report, Report of the Director-General, Geneva, WHO, 1998.
3. Sacks F.M. Am J. Cardiol. 88 Suppl. (2001) 14N
4. Bertolini S., Bon G.B., Campbell L.M., Farnier M., Lagan J., and Mahla G. Atherosclerosis 130 (1997) 191-197
5. Bellosta S., Paoletti R., and Corsini A. Circulation 109 Suppl. III (2004) 50
6. Lins R.L., Katelijne E., Matthys G.A., Verpooten P.C., Peeters M., Dratwa J.C., Stolear N.H., and Lameire. Nephrol. Dial Transplant 18 (2003) 967
7. Wanner C., and Quaschning T. Curr. Opin. Nephrol. Hypertens 10 (2001) 195
8. Touchette M.A., and Slaughter R.L. DICP 25 (1991) 1214
9. Yuan R., and Venitz J. Int. J. Clin. Pharmacol. Ther. 38 (2000) 245
10. Jemal M., and Xia Y.Q. J. Pharm. Biomed. Anal. 22 (2000) 813
11. Yang D.J., and Hwang L.S. J. Chromatogr. A 1119 (2006) 277
12. Erturk S., Onal A., and Cetin S.M. J. Chromatogr. B 793 (2003) 193
13. Nirogi R., Mudigonda K., and Kandikere V. J. Pharm. Biomed. Anal. 44 (2007) 379
14. Jacobsen W., Kuhn B., Soldner A., Kirchner G., Sewing K.F., Kollman P.A., Benet L.Z., and Christians U. Drug. Metab. Dispos. 28 (2000) 1369
15. Nováková L., Šatínský D., and Solich P. Trends Anal. Chem. 27 (2008) 352
16. Barrett B., Huclová J., Bořek-Dohalský V., Němec B., and Jelínek I. J. Pharm. Biomed. Anal. 41 (2006) 517
17. Jemal M., Ouyang Z., and Powell M.L. J. Pharm. Biomed. Anal. 23 (2000) 323
18. Yang H., Feng Y., and Luan Y. J. Chromatogr. B 785 (2003) 369
19. Zhao J.J., Yang A.Y., and Rogers J.D. J. Mass Spectrom. 37 (2002) 421
20. Yang A.Y., Sun L., Musson D.G., and Zhao J.J. J. Pharm. Biomed. Anal. 38 (2005) 521
21. Zhang N., Yang A., Rogers J.D., and Zhao J.J. J. Pharm. Biomed. Anal. 34 (2004) 175
22. Jemal M., Ouyang Z., Chen B.Ch., and Teitz D. Rapid Commun. Mass Spectrom. 13 (1999) 1003
23. Bullen W.W., Miller R.A., and Hayes R.N. J. Am. Soc. Mass. Spectrom. 10 (1999) 55
24. Nigori R.V.S., Kandikere V.N., Shukla M., Mudigonda K., Maurya S., Boosi R., and Anjaneyulu Y. Biomed. Chromatogr. 20 (2006) 924
25. Van Pelt C.K., Corso T.N., Schultz G.A., Lowes S., and Henion J. Anal. Chem. 73 (2001) 582
26. European Pharmacopoeia, 5th edition (Ph. Eur. 5), Council of Europe, Strasbourg, 2004.
27. United States Pharmacopoeia 30, United States Pharmacopoeial Convention, Rockville, MD 20852, United States, 2007.
28. International Conference on Harmonization (ICH), Q2(R1): Text on Validation of Analytical Procedures, US FDA Federal Register, 2003.
29. Kruger P.S., Freir N.M., Venkatesh B., Robertson T.A., Roberts M.S., and Jones M. Intensive Care Med. 35 (2009) 717
30. Daugirdas J.T. Simplified equations for monitoring Kt/V, PCRn, eKt/V and ePCRn. Adv. Ren. Replac. Ther. 2 (1995) 295
31. Holcapek M., Volna K., Jandera P., Kolarova L., Lemr K., Exner M., and Cirkva A. J. Mass Spectrom. 39 (2004) 43
32. Miao X.S., and Metcalfe Ch.D. J. Chromatogr. A 998 (2003) 133
33. Lea A.P., and McTavish D. Drugs 53 (1997) 828
34. Thummel K.E., and Wilkinson G.R. Annu. Rev. Pharmacol. Toxicol. 38 (1998) 389